UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040918
Receipt number R000046307
Scientific Title Randomized control trial of esophago-gastrostomy versus double-tract in laparoscopic proximal gastrectomy
Date of disclosure of the study information 2020/06/27
Last modified on 2020/06/27 17:31:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized control trial of esophago-gastrostomy versus double-tract in laparoscopic proximal gastrectomy

Acronym

Randomized control trial of esophago-gastrostomy versus double-tract in laparoscopic proximal gastrectomy

Scientific Title

Randomized control trial of esophago-gastrostomy versus double-tract in laparoscopic proximal gastrectomy

Scientific Title:Acronym

Randomized control trial of esophago-gastrostomy versus double-tract in laparoscopic proximal gastrectomy

Region

Japan


Condition

Condition

Gastric Cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the best reconstruction method after laparoscopic proximal gastrectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Percentage of weight loss 1 year after surgery.

Key secondary outcomes

Operative time, Complication, The percentage of conversion to laparotomy, Nutritional assessment, Reflux esophagitis, Recurrence-free survival, Overall Survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

The arm of esophagogastrostomy.

Interventions/Control_2

The arm of double tract reconstruction.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically diagnosed unresectable advanced or recurrent gastric or esophagogastric junction adenocarcinoma.
2) Scheduled for Proximal gastrectomy.
3) cStage I.
4) Age over 20 years old.
5) PS:0-2(ECOG).
6) BMI under 30.
8) No history of upper abdominal surgery
9) No history of chemotherapy, radiation, hormone therapy, molecular target drugs.
6) Written informed consent.

Key exclusion criteria

1) With double cancer.
2) Have an infectious disease that requires systemic treatment.
3) Pregnant or lactating.
4) Psychosis.
5) Administration of steroids.
6) History of myocardial infarction.
7) With uncontrolled hypertension.
8) With uncontrolled diabetes.
9) With respiratory disease requiring continuous oxygen administration.
10) Renal failure requiring hemodialysis.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Yamasaki

Organization

Graduated School of Medicine, Osaka University

Division name

Department of Gastroenterological Surgery

Zip code

565-0871

Address

2-2-E2, Yamadaoka, Suita City, Osaka

TEL

06-6879-3251

Email

myamasaki@gesurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Yamasaki

Organization

Graduated School of Medicine, Osaka University

Division name

Department of Gastroenterological Surgery

Zip code

565-0871

Address

2-2-E2, Yamadaoka, Suita City, Osaka

TEL

06-6879-3251

Homepage URL


Email

myamasaki@gesurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Oasaka University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka International Cancer Institute

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University

Address

2-2-E2, Yamadaoka, Suita City, Osaka

Tel

06-6879-3251

Email

myamasaki@gesurg.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

19206-2

Org. issuing International ID_1

Osaka International Cancer Institute

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 05 Month 18 Day

Date of IRB


Anticipated trial start date

2020 Year 06 Month 15 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 27 Day

Last modified on

2020 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046307


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name